Effectiveness of pelvic lymphadenectomy in the treatment of prostate cancer
- Authors: Shershnev S.P1, Reinyuk O.L1, Savilov A.V1, Levkovskii A.N1, Krainyukov P.E1, Babskii V.I1, Makanin M.A1
-
Affiliations:
- PKU "Central military clinical hospital named after P. V. Mandryka" MO RF
- Issue: Vol 340, No 5 (2019)
- Pages: 39-46
- Section: Articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/81646
- DOI: https://doi.org/10.17816/RMMJ81646
Cite item
Abstract
Full Text

About the authors
S. P Shershnev
PKU "Central military clinical hospital named after P. V. Mandryka" MO RF
Email: info@2cvkg.ru
Moscow
O. L Reinyuk
PKU "Central military clinical hospital named after P. V. Mandryka" MO RFMoscow
A. V Savilov
PKU "Central military clinical hospital named after P. V. Mandryka" MO RFMoscow
A. N Levkovskii
PKU "Central military clinical hospital named after P. V. Mandryka" MO RFMoscow
P. E Krainyukov
PKU "Central military clinical hospital named after P. V. Mandryka" MO RFMoscow
V. I Babskii
PKU "Central military clinical hospital named after P. V. Mandryka" MO RFMoscow
M. A Makanin
PKU "Central military clinical hospital named after P. V. Mandryka" MO RFMoscow
References
- Алексеев Б.Я., Нюшко К.М., Воробьев Н.В. Частота и локализация метастазов в лимфатических узлах при выполнении радикальной простатэктомии и расширенной тазовой лимфаденэктомии у больных раком предстательной железы // Онкоурология. - 2012. - № 1. - С. 77-81.
- Коган М.И., Лоран О.Б., Петров С.Б. Радикальная хирургия рака предстательной железы. - М. ГЭОТАР-Медиа, 2006. - 351 с.
- Петров С.Б. Хирургия предстательной железы. - СПб: Изд-во Сергея Ходова, 2004. - 270 с.
- Пушкарь Д.Ю., Раснер П.И. Диагностика и лечение локализованного рака предстательной железы. - М.: МЕДпресс-информ, 2008. - 311 с.
- Allaf M.E., Palapattu G.S., Trock B.J. et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer // J. Urol. - 2004. - Vol. 172. - P. 1840-1844.
- Bader P., Burkhard F.C., Markwalder R. et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? // J. Urol. - 2003. - Vol. 169. - P. 849-854.
- Bray F., Lortet-Tieulent J., Ferlay J. et al. Prostate cancer incidence and mortality trends in 37 European countries: an overview // Eur. J. Cancer. - 2010. - Vol. 46. - P. 3040-3052.
- Brendler C., Cleeve L., Anderson E. et al. Staging pelvic lymphadenectomy for carcininoma of the prostate: risk versus benefit // Urology. - 1980. - Vol. 124. - P. 849-850.
- Briganti A., Blute M.L., Eastham J.H. et al. Pelvic lymph node dissection in prostate cancer // Eur. Urol. - 2009. - Vol. 55. - P. 1251-1265.
- Campell S.C., Klein E.A., Levin H.S. et al. Open pelvic lymph node dissection for prostate cancer: a reassessment // Urology. - 1995. - Vol. 46. - P. 352-361.
- Catalona W.J., Miller D.R., Kavoussi L.R. Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy // Urology. - 1988. - Vol. 140. - P. 540-543.
- Сheng C.W., Bergstralh E.J., Zincke H. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy // Cancer. - 1993. - Vol. 71. - P. 996-1008.
- Cheng L., Zincke H., Blute M.L. et al. Risk of prostate carcinoma death in patients with lymph node metastasis // Cancer. - 2001. - Vol. 91. - Р. 66-73.
- D’Amico A.V., Whittington R., Malkowicz S.B. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer // JAMA. - 1998. - Vol. 280. - P. 969-974.
- Danella J.F., deKernion J.B., Smith R.B. et al. The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection // Urol. - 1993. - Vol. 149. - P. 1488-1503.
- Donohue R.E., Mani J.H., Whitesel J.A. et al. Intraoperative and erly complications of staging pelvic lymph node dissection in prostatic adenocarcinoma // Urology. - 1990. - Vol. 35. - P. 223-230.
- Grossfeld G.D., Chang J.J., Broering J.M. et al. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the cancer of the prostate strategic urologic research endeavor database // Urology. - 2001. - Vol. 165. - P. 851-856.
- Han M., Partin A.W., Pound C.R. et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience // Urol. Clin. N. Am. - 2001. - Vol. 28. - P. 555-565.
- Heidenreich A., Bellmunt J., Bolla M. et al. EAU guidelines on prostate cancer, I: screening, diagnosis, and treatment of clinically localised disease // Eur. Urol. - 2011. - Vol. 59. - P. 61-71.
- Heidenreich A., Ohlmann C.H., Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy // Eur. Urol. - 2007. - Vol. 52. - P. 29-37.
- Ji J., Yuan H., Wang L., Hou J. Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study // J. Surg. Res. - 2012. - Vol. 178. - P. 779-784.
- Joslyn S.A., Konety B.R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer // Urology. - 2006. - Vol. 68. - P. 121-125.
- Kattan M.W., Eastham J.A., Stapleton A.M. et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer // J. Natl. Cancer Inst. - 1998. - Vol. 90. - P. 766-771.
- Liedberg F., Kjolhede H., Sundqvist P. Laparoscopic extended pelvic lymphadenectomy for staging can be performed with limited morbidity and short hospital stay in patients with prostate cancer // Scand. J. Urol. Nephrol. - 2012. - Vol. 46. - P. 332-336.
- Parra R.O., Isorna S., Perez M.G. et al. Radical perineal prostatectomy without pelvic lymphadenectomy: selection criteria and early results // Urology. - 1996. - Vol. 155. - P. 612-625.
- Partin A.W., Yoo J., Carter H.B. et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer // Urology. - 1993. - Vol. 150. - P. 110-114.
- Partin A.W., Kattan M.W., Subong E.N. et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update // JAMA. - 1997. - Vol. 277. - P. 1445-1451.
- Partin A.W., Mangold L.A., Lamm D.M. et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium // Urology. - 2001. - Vol. 58. - P. 843-848.
- Schroder F.H., Hugosson J. Prostate cancer mortality at 11 years of follow up. ERSPC Investigators // N. Engl. J. Med. - 2012. - Vol. 366. - P. 981-987.
- Schumacher M.C., Burkhard F.C., Thalmann G.N. et al. Is pelvic lymph node dissection necessary in patients with a serum PSAo10 ng/ml undergoing radical prostatectomy for prostate cancer? // Eur. Urol. - 2006. - Vol. 50. - P. 272-279.
- Schwerfeld-Bohr J., Kaemper M., Krege S., Heidenreich A. Prospective randomized multicenter study comparing limited vs extended pelvic lymphadenectomy in intermediate and high risk prostate cancer-first descriptive results (SEAL, AUO AP 55/09) // Eur. Urol. Suppl. - 2014. - Vol. 13. - P. 747.
- Siegel R., Ma J., Zou Z. et al. Cancer statistics, 2014. CA // Cancer J. Clin. - 2014. - Vol. 64, N 1. - P. 9-29.
- Sivalingam S., Oxley J., Probert J.L. et al. Role of pelvic lymphadenectomy in prostate cancer management // Urology. - 2007. - Vol. 69. - P. 203-209.
- Suardi N., Larchera A., Haese A. et al. Indication for and Extension of Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: An Analysis of Five European Institutions // Eur. Urol. - 2014. - Vol. 66, Iss. 1. - P. 635-643.
- Weingartner K., Ramaswamy A., Bittinger A. et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic // J. Urol. - 1996. - Vol. 156. - P. 1969-1971.
